Patent · US Expired

Piperidine derivatives as CCR5 inhibitors

US7399771B2 · kind B2 · utility

1Cited by

0References

3Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Rainer Albert · Basel, CH
Nigel Graham Cooke · Oberwil, CH
Gebhard Thoma · Lörrach, DE
Christian Bruns · Glückstadt, DE
Francois Nuninger · Wittenheim, FR
Markus Streiff · Birsfelden, CH
Hans-Gunter Zerwes · Lörrach, DE

Key dates

Filing date	Oct 6, 2003
Grant date	Jul 15, 2008
Priority date	—
Expiry date	Oct 6, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds of formula I:wherein R1, R2, R3 and X are as defined herein, in free or salt form, which are useful as CCR5 inhibitors, e.g. in the prevention or treatment of disorders mediated by interactions between chemokine receptors and their ligands.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.